VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ARDT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ARDTArdent Health Inc.
$17.75$2.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksARDTCash Flow

Ardent Health Inc. (ARDT) Cash Flow Statement

7Y historyFree accessUpdated daily

Free cash flow margins ranged from -5.5% in 2026Q1 to 9.7% in 2026Q2, with working capital changes of -$160.1M and +$107.5M indicating that cash conversion depends heavily on receivables timing rather than steady earnings quality.

Income StatementBalance SheetCash FlowRatios

ARDT Cash Flow Statement

Annual statement

ARDT Cash Flow Statement

Ardent Health Inc. (ARDT) cash flow statement — 7-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'18Dec'17Dec'16
Cash from Operations480.26M470.51M315.03M221.7M-38.36M159.59M119.47M85.78M
Operating CF Margin %-7.44%5.28%4.1%-0.75%3.83%3.98%4.07%
Operating CF Growth %-9.67%49.36%42.1%677.96%-124.04%33.58%39.28%-
Net Income146.22M230.13M299.71M128.98M265.37M-143.02M-35.65M14.6M
Depreciation & Amortization166.42M155.7M146.29M140.84M138.17M143.19M109.53M71.51M
Stock-Based Compensation33.3M39.29M17.98M904K611K000
Deferred Taxes3.07M43.59M24.04M4M46.12M-7.82M49.7M-12.71M
Other Non-Cash Items23.7M5.13M8.76M3.29M-478.89M152.7M45.83M43.08M
Working Capital Changes22.94M-3.34M-181.75M-56.31M-9.74M14.54M-49.94M-30.71M
Change in Receivables33.43M59.16M40M-181.1M-17.18M-9.05M-63.82M-17.72M
Change in Inventory5.12M-3.15M-9.41M1.67M4.67M-1.03M-3.61M56K
Change in Payables-2.15M62.06M-103.86M136.82M14.42M37.15M41.3M-9.28M
Cash from Investing-193.45M-214.23M-220.46M-137.98M46.58M-482.14M-966.93M-64.83M
Capital Expenditures-150.76M-211.9M-187.51M-137.41M-151.11M-160.66M-121.53M-80.5M
CapEx % of Revenue2.34%3.35%3.14%2.54%2.95%3.86%4.05%3.82%
Acquisitions-2.5M-2.5M-31.25M0206.37M-349.83M-857.55M-2.5M
Investments--------
Other Investing-40.18M179K-1.71M-575K-8.69M28.35M12.16M18.17M
Cash from Financing-131.63M-103.47M24.64M-102.26M-270.33M353.22M826.81M-25.89M
Debt Issued (Net)-22.23M-7.99M-104.77M-7.03M-16.41M252.63M718.51M-5.67M
Equity Issued (Net)-24.01M0208.66M0099.12M143.94M0
Dividends Paid0000-174.81M000
Share Repurchases-24.01M0000000
Other Financing-85.39M-95.48M-79.24M-95.24M-79.11M1.47M-35.64M-20.22M
Net Change in Cash156.8M152.82M119.21M-18.55M-262.11M-12.3M-20.65M-4.95M
Free Cash Flow280.69M258.61M127.52M84.29M-189.47M-1.07M-2.06M3.62M
FCF Margin %4.35%4.09%2.14%1.56%-3.69%-0.03%-0.07%0.17%
FCF Growth %81.22%102.8%51.28%144.49%-17590.57%48.06%-156.96%-
FCF per Share1.981.830.960.59-1.32-0.01-0.010.03
FCF Conversion (FCF/Net Income)1.92x3.46x1.50x4.41x-0.20x-1.12x-3.35x5.87x
Interest Paid0074.98M81.61M90.85M86.54M64.63M26.01M
Taxes Paid0041.6M19.43M55.82M5.55M2.37M23.62M

Key Metrics

Growth RegimeMixed
ProfitabilityWeak
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Working capital reversals and earnings gap

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Operating Cash Flow Diverges From Earnings

Based on reported figures, ARDT's operating cash flow has swung widely against net income, with OCF/NI ratios ranging from negative 1.51 in 2026Q1 to 11.64 in 2026Q2, indicating that quarterly cash conversion is driven more by timing than by steady earnings quality.

The extreme quarter-to-quarter ratios suggest that reported net income is a poor predictor of cash generation for this company over short windows. Investors should monitor whether the 2026Q2 spike, which coincided with a $107.5M working capital inflow, reverses in subsequent periods, as the Q1 negative OCF despite positive earnings implies receivables or other balances absorbed significant cash. This pattern warrants further investigation into the underlying drivers of working capital before treating any single quarter as representative of normalized conversion.

Working Capital Swings Dominate Cash Generation

As reported in financial statements, ARDT's working capital change of negative $160.1M in 2026Q1 and negative $127.5M in 2025Q1 contrasts sharply with inflows of $107.5M and $83.1M in other quarters, suggesting receivables timing is a principal driver of reported cash flow volatility.

The recurring first-quarter outflows in both 2025 and 2026 suggest a possible seasonal pattern in receivables collection or payer settlement timing rather than a one-time event. Because the company's revenue has held near $1.6B, the magnitude of these swings relative to the revenue base implies that collection efficiency is a material variable for free cash flow. Without disclosure of days sales outstanding or self-pay bad debt trends, the cause of these reversals cannot be confirmed from the supplied data.

Free Cash Flow Margins Remain Thin and Volatile

According to reported earnings, ARDT's free cash flow margin ranged from negative 5.5% in 2026Q1 to 9.7% in 2026Q2, with the trailing sequence failing to establish a consistent upward trajectory across the ten reported quarters.

Free cash flow generation appears highly dependent on the working capital cycle rather than on a stable operating base, which limits its usefulness as a standalone valuation anchor. The most recent quarter's 4.5% margin, while positive, sits below the 2026Q2 peak and suggests that the favorable Q2 result was not sustained. Investors should treat trailing free cash flow with caution until multiple consecutive quarters confirm a durable margin level.

Capital Spending Remains Moderate Against Revenue

Based on ARDT's reported figures, capital expenditures have ranged from 1.5% to 5.2% of revenue across recent quarters, with the 2024Q4 and 2025Q4 peaks of roughly 5% suggesting periodic facility or equipment investment cycles rather than uniform maintenance spend.

Quarterly D&A of roughly $37M to $43M sits below the peak CapEx quarters, suggesting that the company has at times invested above its depreciation base, which may indicate growth or modernization spending alongside maintenance needs. The data does not separate maintenance from growth capital, so the portion of spending that is discretionary cannot be determined from the supplied figures. The lumpiness of these outlays appears to amplify the volatility already present in operating cash flow.

Reported Cash Strength May Overstate Durability

The strongest bear case is that ARDT's positive free cash flow in several quarters depends heavily on working capital inflows, which may reverse, leaving underlying cash generation weaker than headline quarterly results suggest.

Cumulative free cash flow across the ten quarters is materially less stable than any single strong quarter implies, with multiple negative FCF periods offsetting the positive ones. Combined with a thin net margin of 2.1% and a debt-to-equity ratio of 1.34, limited earnings cushion could constrain the company's ability to absorb a prolonged working capital drag. Investors should monitor whether reported cash flow improvements persist without reliance on timing benefits from receivables.

ARDT — Frequently Asked Questions

Quick answers to the most common questions about buying ARDT stock.

How much cash does Ardent Health Inc. (ARDT) generate from operations?

Ardent Health Inc. (ARDT) generated $470.5M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Ardent Health Inc.'s free cash flow?

Ardent Health Inc. (ARDT) generated $258.6M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Ardent Health Inc.'s capital expenditure (CapEx)?

Ardent Health Inc. (ARDT) spent $211.9M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.